Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Pharmaceutical Drug Import from EEU Countries to Russia (April 2018)

Wednesday, June 6, 2018

Between January and April 2018, Russia imported 3.7 bin RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices, VAT included), which is in monetary terms 58.2% higher than that of the same period of 2017. Despite the growth in monetary terms, in physical terms, the import amounted to around 3.7 mln units, which is 15.3% lower than that of the same period of 2017.

The big difference in dynamics is due to the new import structure. In particular, the import of Cefotaxime and Ceftriaxone (1g) has fallen considerably over the year, while the import of these drugs (40g) has risen. The dynamics of the total import are 1% if calculated in MDU (minimum dosage units).

Between January and April 2018, Russia imported pharmaceutical drugs of 14 companies of the EEU countries. The absolute leader in monetary terms is Belmedpreparaty (Belarus), which accounts for around 36% of the total import. Its import has fallen by 10% over the year, though. It is follow by Kelun-Kazpharm (Kazakhstan), with a nearly 25 times increase. Since January 2018, the company has been importing only 5 products, mainly Metronidazole and Ciprofloxacine (for infusion).

Over the year, 12 new products has been added to the import line, with Ciprofloxacine and Docetaxel being the leaders (Kelun-Kazhpharm).

Read more about pharmaceutical drug import from EEU countries to Russia (March 2018 results) here: http://rncph.com/news/28_04_2018

Volume and dynamics of pharmaceutical drug import from EEU countries to Russia (wholesale prices, VAT included) (2016 - 2017, January - April 2018)

Share: